Allopurinol (Allopurinol Unicorn)
Allopurinol
Unicorn Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Unicorn Pharmaceuticals (Pty) Ltd
- Certificate holder
- Unicorn Pharmaceuticals (Pty) Ltd
- Registrations
- 2
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Allopurinol 100 unicorn EACH TABLET CONTAINS ALLOPURINOL 100,0 mg | 100/300 mgTablet | 54058354/3.3/0583Approved 27 August 2024 | Registered | S3 | PIPIL |
| Allopurinol 300 unicorn EACH TABLET CONTAINS ALLOPURINOL 300,0 mg | 100/300 mgTablet | 54058454/3.3/0584Approved 27 August 2024 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Allopurinol
S3: Allopurinol
Consolidated Schedules 06 July 2026, line 3130
Pharmacological class: Anti-gout preparations. (class 3.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1,5-Dihydropyrazolo[5,4-d]pyrimidin-4-one
Drag to rotate. Structure from PubChem CID 135401907.
SAHPRA documents
Schedule Verification
This medication's schedule (S3) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.